The Syneos Health Podcast
152 Episoder
-
2023 Health Trends: Personally, Purposefully Building What’s Next
Publisert: 29.11.2022 -
Real World Evidence and Rare Diseases, Part 3: The Value of Registries
Publisert: 3.11.2022 -
Decentralized Clinical Trials: Implications for Biotech
Publisert: 5.10.2022 -
Full-Service Commercial
Publisert: 21.9.2022 -
MAPS Edition: Value Demonstration - A View From the Top
Publisert: 8.8.2022 -
MAPS Edition: Bringing Medical Affairs Into the C-Suite
Publisert: 8.8.2022 -
Opportunities and Challenges in Cell and Gene Therapy
Publisert: 14.7.2022 -
MAPS Edition: Recruiting for the New Profile of Medical Affairs
Publisert: 1.7.2022 -
MAPS Edition: Stakeholder Engagement in a Data-Driven Environment
Publisert: 27.6.2022 -
MAPS Edition: Measuring the Immeasurable: Value and Impact of Medical Affairs
Publisert: 8.6.2022 -
MAPS Edition: Be Bold - Preparing Medical Affairs for 2030 and Beyond
Publisert: 20.5.2022 -
Training the Next Generation of Pharma
Publisert: 13.5.2022 -
Getting Access
Publisert: 27.4.2022 -
Epilepsy, the Central Nervous System and Rare Disease
Publisert: 13.4.2022 -
The Placebo Effect
Publisert: 23.3.2022 -
Mental Health in Rare Disease
Publisert: 9.2.2022 -
Navigating the Rare Disease Landscape
Publisert: 2.2.2022 -
Business Continuity Through Strategic Outsourcing
Publisert: 5.1.2022 -
The Virtual Sales Organization
Publisert: 3.11.2021 -
Thirty Years of Physician Answers
Publisert: 16.9.2021
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.